Back to Clinical Trials Overview

Your search for "Aging" returned 19 results:


Seniors' Health Literacy, Beliefs, and Asthma Self-Management
Principal Investigator(s): Federman, Alex D.

Function and structure of human olfactory system with aging in normal subjects
Principal Investigator(s): Tang, Cheuk Ying

Prolonging Remission in Depressed Elderly
Principal Investigator(s): Kellner, Charles

Inflammation, long-term diabetes characteristics, and cognitive decline
Principal Investigator(s): Schnaider-Beeri, Michal

A Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of MK-8931 in Subjects with Mild to Moderate Alzheimer's Disease (EPOCH)
Principal Investigator(s): Judith Neugroschl

Effects of Glycoxidative Stress on Human Aging
Principal Investigator(s): Vlassara, Helen

Computerized cognitive intervention in the oldest-old: A feasibility study
Principal Investigator(s): Michal Schnaider-Beeri

Late Effects of Traumatic Brain Injury
Principal Investigator(s): Wayne Gordon

Improving Pain and Function in Hip Fracture
Principal Investigator(s): Morrison, Sean R

Protocol H8A-MC-LZAZ(a)/ADC-040-A4 Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Principal Investigator(s): Mary Sano

Functional Deficits of ACC in MCI
Principal Investigator(s): Jin Fan

The Study of Nasal Insulin to Fight Forgetfulness
Principal Investigator(s): Hillel Grossman

Alzheimer’s Disease Neuroimaging Initiative-2 (ADNI-2)
Principal Investigator(s): Hillel Grossman

The Effects of Glycoxidation on Cognition
Principal Investigator(s): Schnaider-Beeri, Michal

Neural & Cognitive Correlates of Glucocorticoid Response in Posttraumatic Stress Disorder
Principal Investigator(s): Yehuda, Rachel Ph.D.

NOBLE: A Phase 2 multi-center randomized double-blind placebo-controlled study to evaluate the efficacy and safety of T-817 in patients with mild to moderate Alzheimer's disease
Principal Investigator(s): Amy Aloysi

Home Based Assessment of Elderly at Risk/Cognitive Decline
Principal Investigator(s): Sano, Mary

Health Insurance Navigators for Low Income Elderly
Principal Investigator(s): Federman, Alex D.

The TOMMORROW Study: A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Simultaneously Qualify a Biomarker Algorithm for Prognosis of Risk of Developing Mild Cognitive Impairment due to Alzheimer's Disease (MCI due to AD) and to Test the Safety and Efficacy of Pioglitazone (AD-4833 SR 0.8 mg QD) to Delay the Onset of MCI due to AD in Cognitively Normal Subjects
Principal Investigator(s): Judith Neugroschl